Clinical Trials for MM-111

1 Open Trial

Trial TypeProtocol No. &
Open Date
Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel with Trastuzumab in Patients with HER2 Positive Carinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.